Skip Nav Destination
Issues
December 2019
-
Cover Image
Cover Image
Cover: Credit: Jing Jing Tsong. For more information, please visit theispot.com.
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
ISSN 0149-5992
EISSN 1935-5548
In this Issue
In This Issue
In This Issue of Diabetes Care
Diabetes Care November 2019, Vol.42, 2159-2160. doi:https://doi.org/10.2337/dc19-ti12
Commentaries
A Verdict for Glimepiride: Effective and Not Guilty of Cardiovascular Harm
Diabetes Care November 2019, Vol.42, 2161-2163. doi:https://doi.org/10.2337/dci19-0034
Diabetes in Normal-Weight Individuals: High Susceptibility in Nonwhite Populations
Diabetes Care November 2019, Vol.42, 2164-2166. doi:https://doi.org/10.2337/dci19-0046
Profiles in Progress
Fred W. Whitehouse, MD, MACP (1926–2019)
Diabetes Care November 2019, Vol.42, 2167-2170. doi:https://doi.org/10.2337/dci19-0057
Clinical Care / Education / Nutrition / Psychosocial Research
Reduction in Glycated Hemoglobin and Daily Insulin Dose Alongside Circadian Clock Upregulation in Patients With Type 2 Diabetes Consuming a Three-Meal Diet: A Randomized Clinical Trial
Daniela Jakubowicz; Zohar Landau; Shani Tsameret; Julio Wainstein; Itamar Raz; Bo Ahren; Nava Chapnik; Maayan Barnea; Tali Ganz; Miriam Menaged; Naomi Mor; Yosefa Bar-Dayan; Oren Froy
Diabetes Care September 2019, Vol.42, 2171-2180. doi:https://doi.org/10.2337/dc19-1142
Changes in Consumption of Sugary Beverages and Artificially Sweetened Beverages and Subsequent Risk of Type 2 Diabetes: Results From Three Large Prospective U.S. Cohorts of Women and Men
Jean-Philippe Drouin-Chartier; Yan Zheng; Yanping Li; Vasanti Malik; An Pan; Shilpa N. Bhupathiraju; Deirdre K. Tobias; JoAnn E. Manson; Walter C. Willett; Frank B. Hu
Diabetes Care October 2019, Vol.42, 2181-2189. doi:https://doi.org/10.2337/dc19-0734
One Year Clinical Experience of the First Commercial Hybrid Closed-Loop System
Diabetes Care September 2019, Vol.42, 2190-2196. doi:https://doi.org/10.2337/dc19-0855
Genetic Prediction of Serum 25-Hydroxyvitamin D, Calcium, and Parathyroid Hormone Levels in Relation to Development of Type 2 Diabetes: A Mendelian Randomization Study
Diabetes Care September 2019, Vol.42, 2197-2203. doi:https://doi.org/10.2337/dc19-1247
Epidemiology / Health Services Research
Using Real-World Data to Predict Findings of an Ongoing Phase IV Cardiovascular Outcome Trial: Cardiovascular Safety of Linagliptin Versus Glimepiride
Elisabetta Patorno; Sebastian Schneeweiss; Chandrasekar Gopalakrishnan; David Martin; Jessica M. Franklin
Diabetes Care July 2019, Vol.42, 2204-2210. doi:https://doi.org/10.2337/dc19-0069
Racial/Ethnic Disparities in the Prevalence of Diabetes and Prediabetes by BMI: Patient Outcomes Research To Advance Learning (PORTAL) Multisite Cohort of Adults in the U.S.
Yeyi Zhu; Margo A. Sidell; David Arterburn; Matthew F. Daley; Jay Desai; Stephanie L. Fitzpatrick; Michael A. Horberg; Corinna Koebnick; Emily McCormick; Caryn Oshiro; Deborah R. Young; Assiamira Ferrara
Diabetes Care September 2019, Vol.42, 2211-2219. doi:https://doi.org/10.2337/dc19-0532
Incidences of Severe Hypoglycemia and Diabetic Ketoacidosis and Prevalence of Microvascular Complications Stratified by Age and Glycemic Control in U.S. Adult Patients With Type 1 Diabetes: A Real-World Study
Jeremy H. Pettus; Fang Liz Zhou; Leah Shepherd; Ronald Preblick; Phillip R. Hunt; Sachin Paranjape; Kellee M. Miller; Steven V. Edelman
Diabetes Care September 2019, Vol.42, 2220-2227. doi:https://doi.org/10.2337/dc19-0830
Who Is Enrolling? The Path to Monitoring in Type 1 Diabetes TrialNet’s Pathway to Prevention
Emily K. Sims; Susan Geyer; Suzanne Bennett Johnson; Ingrid Libman; Laura M. Jacobsen; David Boulware; Lisa E. Rafkin; Della Matheson; Mark A. Atkinson; Henry Rodriguez; Maria Spall; Helena Elding Larsson; Diane K. Wherrett; Carla J. Greenbaum; Jeffrey Krischer; Linda A. DiMeglio; the Type 1 Diabetes TrialNet Study Group
Diabetes Care September 2019, Vol.42, 2228-2236. doi:https://doi.org/10.2337/dc19-0593
Variability in Glycated Hemoglobin and Risk of Poor Outcomes Among People With Type 2 Diabetes in a Large Primary Care Cohort Study
Diabetes Care October 2019, Vol.42, 2237-2246. doi:https://doi.org/10.2337/dc19-0848
The Impact of Biomarker Screening and Cascade Genetic Testing on the Cost-Effectiveness of MODY Genetic Testing
Diabetes Care September 2019, Vol.42, 2247-2255. doi:https://doi.org/10.2337/dc19-0486
Medical Costs Among Youth Younger Than 20 Years of Age With and Without Diabetic Ketoacidosis at the Time of Diabetes Diagnosis
Diabetes Care October 2019, Vol.42, 2256-2261. doi:https://doi.org/10.2337/dc19-1041
Emerging Therapies: Drugs and Regimens
Efficacy, Safety, and Tolerability of Oral Semaglutide Versus Placebo Added to Insulin With or Without Metformin in Patients With Type 2 Diabetes: The PIONEER 8 Trial
Bernard Zinman; Vanita R. Aroda; John B. Buse; Bertrand Cariou; Stewart B. Harris; Søren Tetens Hoff; Karen Boje Pedersen; Mads Jeppe Tarp-Johansen; Eiichi Araki; PIONEER 8 Investigators
Diabetes Care July 2019, Vol.42, 2262-2271. doi:https://doi.org/10.2337/dc19-0898
Oral Semaglutide Versus Empagliflozin in Patients With Type 2 Diabetes Uncontrolled on Metformin: The PIONEER 2 Trial
Helena W. Rodbard; Julio Rosenstock; Luis H. Canani; Chaicharn Deerochanawong; Janusz Gumprecht; Søren Østergaard Lindberg; Ildiko Lingvay; Anette Luther Søndergaard; Marianne Bach Treppendahl; Eduard Montanya; PIONEER 2 Investigators
Diabetes Care October 2019, Vol.42, 2272-2281. doi:https://doi.org/10.2337/dc19-0883
Pathophysiology / Complications
Prospective Study of Neuropathic Symptoms Preceding Clinically Diagnosed Diabetic Polyneuropathy: ADDITION-Denmark
Laura L. Määttä; Morten Charles; Daniel R. Witte; Lasse Bjerg; Marit E. Jørgensen; Troels S. Jensen; Signe T. Andersen
Diabetes Care September 2019, Vol.42, 2282-2289. doi:https://doi.org/10.2337/dc19-0869
Plasma Copeptin and Risk of Lower-Extremity Amputation in Type 1 and Type 2 Diabetes
Louis Potier; Ronan Roussel; Michel Marre; Petter Bjornstad; David Z. Cherney; Ray El Boustany; Frédéric Fumeron; Nicolas Venteclef; Jean-François Gautier; Samy Hadjadj; Kamel Mohammedi; Gilberto Velho
Diabetes Care October 2019, Vol.42, 2290-2297. doi:https://doi.org/10.2337/dc19-1062
Cardiovascular and Metabolic Risk
Machine Learning to Predict the Risk of Incident Heart Failure Hospitalization Among Patients With Diabetes: The WATCH-DM Risk Score
Matthew W. Segar; Muthiah Vaduganathan; Kershaw V. Patel; Darren K. McGuire; Javed Butler; Gregg C. Fonarow; Mujeeb Basit; Vaishnavi Kannan; Justin L. Grodin; Brendan Everett; Duwayne Willett; Jarett Berry; Ambarish Pandey
Diabetes Care September 2019, Vol.42, 2298-2306. doi:https://doi.org/10.2337/dc19-0587
Type 1 Diabetes Accelerates Progression of Coronary Artery Calcium Over the Menopausal Transition: The CACTI Study
Amena Keshawarz; Laura Pyle; Amy Alman; Caprice Sassano; Elizabeth Westfeldt; Rachel Sippl; Janet Snell-Bergeon
Diabetes Care September 2019, Vol.42, 2315-2321. doi:https://doi.org/10.2337/dc19-1126
Prediabetes and Risk for Cardiovascular Disease by Hypertension Status in Black Adults: The Jackson Heart Study
Demetria Hubbard; Lisandro D. Colantonio; Rikki M. Tanner; April P. Carson; Swati Sakhuja; Byron C. Jaeger; Robert M. Carey; Laura P. Cohen; Daichi Shimbo; Mark Butler; Alain G. Bertoni; Aisha T. Langford; John N. Booth, III; Jolaade Kalinowski; Paul Muntner
Diabetes Care October 2019, Vol.42, 2322-2329. doi:https://doi.org/10.2337/dc19-1074
Novel Communications in Diabetes
A Multidisciplinary Evaluation of a Virtually Supervised Home-Based High-Intensity Interval Training Intervention in People With Type 1 Diabetes
Sam N. Scott; Sam O. Shepherd; Rob C. Andrews; Parth Narendran; Tejpal S. Purewal; Florence Kinnafick; Daniel J. Cuthbertson; Sandra Atkinson-Goulding; Tom Noon; Anton J.M. Wagenmakers; Matt Cocks
Diabetes Care September 2019, Vol.42, 2330-2333. doi:https://doi.org/10.2337/dc19-0871
Visit-to-Visit Fasting Glucose Variability in Young Adulthood and Hippocampal Integrity and Volume at Midlife
Zhenyu Xiong; Jiaying Li; Xiangbin Zhong; Shaozhao Zhang; Xiuting Sun; Huimin Zhou; Yunzhi Chen; Xiaodong Zhuang; Xinxue Liao
Diabetes Care September 2019, Vol.42, 2334-2337. doi:https://doi.org/10.2337/dc19-0834
Review
Setting the Stage for Islet Autoimmunity in Type 2 Diabetes: Obesity-Associated Chronic Systemic Inflammation and Endoplasmic Reticulum (ER) Stress
Diabetes Care November 2019, Vol.42, 2338-2346. doi:https://doi.org/10.2337/dc19-0475
Errata
Erratum. Baseline Characteristics of the Vitamin D and Type 2 Diabetes (D2d) Study: A Contemporary Prediabetes Cohort That Will Inform Diabetes Prevention Efforts. Diabetes Care 2018;41:1590–1599
Erin S. LeBlanc; Richard E. Pratley; Bess Dawson-Hughes; Myrlene A. Staten; Patricia R. Sheehan; Michael R. Lewis; Anne Peters; Sun H. Kim; Ranee Chatterjee; Vanita R. Aroda; Chhavi Chadha; Lisa M. Neff; Irwin G. Brodsky; Clifford Rosen; Cyrus V. Desouza; John P. Foreyt; Daniel S. Hsia; Karen C. Johnson; Philip Raskin; Sangeeta R. Kashyap; Patrick O’Neil; Lawrence S. Phillips; Neda Rasouli; Emilia P. Liao; David C. Robbins; Anastassios G. Pittas; for the D2d Research Group
Diabetes Care September 2019, Vol.42, 2347. doi:https://doi.org/10.2337/dc19-er12
Erratum. Preoperative Circulating Succinate Levels as a Biomarker for Diabetes Remission After Bariatric Surgery. Diabetes Care 2019;42:1956–1965
Victoria Ceperuelo-Mallafré; Gemma Llauradó; Noelia Keiran; Ester Benaiges; Brenno Astiarraga; Laia Martínez; Silvia Pellitero; Jose Miguel González-Clemente; Amaia Rodríguez; José Manuel Fernández-Real; Albert Lecube; Ana Megía; Nuria Vilarrasa; Joan Vendrell; Sonia Fernández-Veledo
Diabetes Care October 2019, Vol.42, 2347. doi:https://doi.org/10.2337/dc19-er12a
Issues and Events
e-Letters
Observations
Effect of Methylprednisolone or Zoledronic Acid on Resolution of Active Charcot Neuroarthropathy in Diabetes: A Randomized, Double-Blind, Placebo-Controlled Study
Diabetes Care October 2019, Vol.42, e185-e186. doi:https://doi.org/10.2337/dc19-1659
Comments and Responses
Response to Comment on Pilemann-Lyberg et al. Uric Acid Is an Independent Risk Factor for Decline in Kidney Function, Cardiovascular Events, and Mortality in Patients With Type 1 Diabetes. Diabetes Care 2019;42:1088–1094
Diabetes Care November 2019, Vol.42, e188. doi:https://doi.org/10.2337/dci19-0037
Comment on Cho et al. Antidiabetic Medications and Mortality Risk in Individuals With Pancreatic Cancer–Related Diabetes and Postpancreatitis Diabetes: A Nationwide Cohort Study. Diabetes Care 2019;42:1675–1683
Anne-Claire Devouge; Ninon Foussard; Pauline Poupon; Marie Monlun; Laurence Blanco; Kamel Mohammedi; Vincent Rigalleau
Diabetes Care November 2019, Vol.42, e189-e190. doi:https://doi.org/10.2337/dc19-1504
Response to Comment on Cho et al. Antidiabetic Medications and Mortality Risk in Individuals With Pancreatic Cancer–Related Diabetes and Postpancreatitis Diabetes: A Nationwide Cohort Study. Diabetes Care 2019;42:1675–1683
Diabetes Care November 2019, Vol.42, e191-e192. doi:https://doi.org/10.2337/dci19-0047
Comment on Kiviniemi et al. Prediabetes and Risk for Cardiac Death Among Patients With Coronary Artery Disease: The ARTEMIS Study. Diabetes Care 2019;42:1319–1325
Diabetes Care November 2019, Vol.42, e193-e194. doi:https://doi.org/10.2337/dc19-1587
